200 related articles for article (PubMed ID: 26416007)
1. Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma.
Haddad AQ; Jiang L; Cadeddu JA; Lotan Y; Gahan JC; Hynan LS; Gupta N; Raj GV; Sagalowsky AI; Margulis V
Urology; 2015 Dec; 86(6):1146-52. PubMed ID: 26416007
[TBL] [Abstract][Full Text] [Related]
2. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
3. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract][Full Text] [Related]
4. Statin use and kidney cancer outcomes: A propensity score analysis.
Nayan M; Finelli A; Jewett MAS; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
Urol Oncol; 2016 Nov; 34(11):487.e1-487.e6. PubMed ID: 27427224
[TBL] [Abstract][Full Text] [Related]
5. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
Gutt R; Tonlaar N; Kunnavakkam R; Karrison T; Weichselbaum RR; Liauw SL
J Clin Oncol; 2010 Jun; 28(16):2653-9. PubMed ID: 20421534
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
7. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
8. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Lin-Tsai O; Stratton KL; Morgan TM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Urol Oncol; 2015 Jan; 33(1):21.e11-21.e17. PubMed ID: 25456998
[TBL] [Abstract][Full Text] [Related]
9. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
10. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
11. Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma.
Berquist SW; Lee HJ; Hamilton Z; Bagrodia A; Hassan AE; Beksaç AT; Dufour CA; Wang S; Mehrazin R; Patterson A; Derweesh IH
Minerva Urol Nefrol; 2017 Oct; 69(5):501-508. PubMed ID: 28376607
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
13. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Lim JH; Jeong IG; Park JY; You D; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Jul; 56(7):498-504. PubMed ID: 26175868
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort.
Haddad AQ; Wood CG; Abel EJ; Krabbe LM; Darwish OM; Thompson RH; Heckman JE; Merril MM; Gayed BA; Sagalowsky AI; Boorjian SA; Margulis V; Leibovich BC
J Urol; 2014 Oct; 192(4):1050-6. PubMed ID: 24704115
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
